Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meiju Ji

Showing results (31-40 of 108) with videos related to

Pageof 11
Sort By:
Molecular and Cellular Probes|October 23, 2023
Screening protective miRNAs and constructing novel lncRNAs/miRNAs/mRNAs networks and prognostic models for triple-negative breast cancerYuelei Zhao, Yichen Song, Yan Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 11, 2020
ACYP2 contributes to malignant progression of glioma through promoting Ca<sup>2+</sup> efflux and subsequently activating c-Myc and STAT3 signalsMengdan Li, Banjun Ruan, Jing Wei, et al.
Theranostics|June 29, 2017
c-Myc is Required for BRAF<sup>V600E</sup>-Induced Epigenetic Silencing by H3K27me3 in TumorigenesisYiping Qu, Qi Yang, Juan Liu, et al.
International Journal of Clinical and Experimental Pathology|November 18, 2014
Association of BRAFV600E mutation with clinicopathological features of papillary thyroid carcinoma: a study on a Chinese populationShu Liu, Bingfei Zhang, Yanru Zhao, et al.
American Journal of Cancer Research|June 6, 2015
High copy number of mitochondrial DNA (mtDNA) predicts good prognosis in glioma patientsYanfang Zhang, Yiping Qu, Ke Gao, et al.
Journal of Nanoscience and Nanotechnology|May 13, 2008
Fabrication and application of single nucleotide polymorphisms library on magnetic nanoparticles using adaptor PCRHongna Liu, Song Li, Meiju Ji, et al.
Cancer|February 28, 2006
Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcomaPeng Hou, Meiju Ji, Bin Yang, et al.
Journal of Biomedical Nanotechnology|August 29, 2013
Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patientsQi Yang, Kexia Wu, Meiju Ji, et al.
Cytogenetic and Genome Research|June 2, 2022
Cohesin RAD21 Gene Promoter Methylation Correlated with Better Prognosis in Breast Cancer PatientsRongrong Cui, Pu Chen, Yuanyuan Wang, et al.
Oncology Letters|February 10, 2018
Increased copy number of mitochondrial DNA predicts poor prognosis of esophageal squamous cell carcinomaHeng Li, Zhufang Tian, Yong Zhang, et al.
Pageof 11

Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
Molecular and Cellular Probes|October 23, 2023
Screening protective miRNAs and constructing novel lncRNAs/miRNAs/mRNAs networks and prognostic models for triple-negative breast cancerYuelei Zhao, Yichen Song, Yan Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 11, 2020
ACYP2 contributes to malignant progression of glioma through promoting Ca<sup>2+</sup> efflux and subsequently activating c-Myc and STAT3 signalsMengdan Li, Banjun Ruan, Jing Wei, et al.
Theranostics|June 29, 2017
c-Myc is Required for BRAF<sup>V600E</sup>-Induced Epigenetic Silencing by H3K27me3 in TumorigenesisYiping Qu, Qi Yang, Juan Liu, et al.
International Journal of Clinical and Experimental Pathology|November 18, 2014
Association of BRAFV600E mutation with clinicopathological features of papillary thyroid carcinoma: a study on a Chinese populationShu Liu, Bingfei Zhang, Yanru Zhao, et al.
American Journal of Cancer Research|June 6, 2015
High copy number of mitochondrial DNA (mtDNA) predicts good prognosis in glioma patientsYanfang Zhang, Yiping Qu, Ke Gao, et al.
Journal of Nanoscience and Nanotechnology|May 13, 2008
Fabrication and application of single nucleotide polymorphisms library on magnetic nanoparticles using adaptor PCRHongna Liu, Song Li, Meiju Ji, et al.
Cancer|February 28, 2006
Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcomaPeng Hou, Meiju Ji, Bin Yang, et al.
Journal of Biomedical Nanotechnology|August 29, 2013
Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patientsQi Yang, Kexia Wu, Meiju Ji, et al.
Cytogenetic and Genome Research|June 2, 2022
Cohesin RAD21 Gene Promoter Methylation Correlated with Better Prognosis in Breast Cancer PatientsRongrong Cui, Pu Chen, Yuanyuan Wang, et al.
Oncology Letters|February 10, 2018
Increased copy number of mitochondrial DNA predicts poor prognosis of esophageal squamous cell carcinomaHeng Li, Zhufang Tian, Yong Zhang, et al.
Pageof 11